NHJK Holding Corporation Limited, an innovative biotech company in Hong Kong Science Park, specializes in the R&D of next-gen molecular diagnostics. We focus on automating and integrating AI into molecular diagnostic technologies. Our emphasis is on digital microfluidic chip technology, harnessing its capabilities for sample preparation, digital PCR, and NGS library preparation.